chr1-169701681-G-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The ENST00000236147.6(SELL):c.960C>A(p.Asp320Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000137 in 1,580,272 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000236147.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SELL | NM_000655.5 | c.960C>A | p.Asp320Glu | missense_variant | 7/9 | ENST00000236147.6 | NP_000646.3 | |
SELL | NR_029467.2 | n.929C>A | non_coding_transcript_exon_variant | 5/7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SELL | ENST00000236147.6 | c.960C>A | p.Asp320Glu | missense_variant | 7/9 | 1 | NM_000655.5 | ENSP00000236147 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000987 AC: 15AN: 152048Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000220 AC: 44AN: 200196Hom.: 1 AF XY: 0.000300 AC XY: 32AN XY: 106694
GnomAD4 exome AF: 0.000141 AC: 202AN: 1428106Hom.: 4 Cov.: 31 AF XY: 0.000195 AC XY: 138AN XY: 707064
GnomAD4 genome AF: 0.0000920 AC: 14AN: 152166Hom.: 0 Cov.: 32 AF XY: 0.000175 AC XY: 13AN XY: 74366
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 03, 2022 | The c.999C>A (p.D333E) alteration is located in exon 7 (coding exon 7) of the SELL gene. This alteration results from a C to A substitution at nucleotide position 999, causing the aspartic acid (D) at amino acid position 333 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at